DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...
DUBLIN, Ireland, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, ...
According to Gartner, 58% of finance functions employed AI in 2024—a 21-percentage-point jump from the prior year. PwC ...
The beauty industry has long harnessed biotechnology — namely taking the most powerful skincare ingredients in nature and recreating them using science to make them more potent, stable, ...
Trinity Biotech plc, a biotechnology company specializing in human diagnostics and diabetes management, announced it has secured an additional $4 million in debt financing from Perceptive Advisors.
Amgen is committed to reducing drug costs, expanding its AmgenNow program, and investing in US manufacturing to gain tariff ...
In today’s fiercely competitive biotech industry, managing tight margins and evolving regulatory environments present major challenges. Add increased risks from geopolitical tensions, growing ...
Bernhard running samples at the DARO lab at the BioTech Connector on the Nebraska Innovation Campus. Photo provided by DARO. DARO, a biotech startup in Lincoln centered around early disease detection ...
Trinity Biotech plc announced a significant step in its transformation plan by appointing Barclays Capital Inc. as its exclusive financial advisor. The company is shifting its focus to developing its ...
PRINCETON, N.J. and SAN DIEGO, Sept. 15, 2025 /PRNewswire/ -- Made Scientific, a leading U.S.-based cell therapy contract development and manufacturing organization (CDMO), and Basilard BioTech, a ...
Investing News Network on MSN
Top 4 Canadian biotech stocks of 2025
Biotech is a dynamic industry that is driving scientific advances and innovation in healthcare. In Canada, the biotech sector ...
The year 2025 was defined by escalating global trade tensions that fundamentally reshaped the pharmaceutical supply chain, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback